Aignostics

Berlin, Germany

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

$34.0M raised

Oct 2024

Series B

Top Investors

HTGF (High-Tech Gruenderfonds)Wellington PartnersIBB VenturesMayo ClinicBoehringer Ingelheim Venture Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Aignostics raised?

Aignostics has raised $34.0M in total funding. The most recent round was Series B. The last funding was announced in October 2024.

Who are Aignostics's investors?

Aignostics's investors include HTGF (High-Tech Gruenderfonds), Wellington Partners, IBB Ventures, Mayo Clinic, Boehringer Ingelheim Venture Fund.

Where is Aignostics headquartered?

Aignostics is headquartered in Berlin, Germany.

What does Aignostics do?

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

What stage is Aignostics at?

Aignostics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 29, 2024.

MLA

"Aignostics — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/aignostics. Accessed June 4, 2026.

APA

VCBacked. (2024). Aignostics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/aignostics

Wikipedia (cite web)

{{cite web |title=Aignostics — Funding & Investors |url=https://www.vcbacked.co/company/aignostics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 29, 2024.